|
|
|
|
|
3291.0: Monday, November 8, 2004: 2:30 PM-4:00 PM | |||
Oral | |||
| |||
| Expanded contraceptive method choice is vital to attracting more women and men to adopt family planning, and to better meeting needs of current and potential users. Clear guidelines on effective method use (mechanisms of use, who should use, contraindications, standard practice recommendations for effective use, etc.), are essential in order to ensure that clients receive effective methods best suited to their needs. It is imperative that family planning practitioners and anyone involved in managing family planning programs keep up to date on both new contraceptive methods and revised guidelines on existing methods. This panel presents new guidelines from the WHO’s Medical Eligibility Criteria for Contraceptive Use, including guidelines for three new hormonal methods (the combined hormonal ring, combined hormonal patch, and etonogestrel-releasing implant), and three conditions that affect contraceptive effectiveness and use (depression, antiretroviral therapy, and known thrombogenic mutations). Practical research findings on the introduction of a new method in field settings (two-day method), and on use of emergency contraception in the US will help participants better manage introduction and provision of those methods. Finally, college students views on acceptability of new contraceptive and STI prevention methods are presented, demonstrating considerations that product developers need to consider in order to improve effectiveness of products introduced in the future. | |||
| Learning Objectives: At the end of this session, participants will be able to: 1) describe new guidelines for use of three new hormonal contraceptive methods 2) name three conditions that have new WHO guidelines for contraceptive use 3) articulate guidelines for contracptive use by women with HIV/AIDS 4) describe results of practical field experience with relatively new methods such as the two day method and emergency contraception 5) Discuss the importance of acceptability research in the development of biomedical prevention methods | |||
| S. Marie Harvey, DrPH | |||
Breaking News: Updates on WHO’s Guidance for Contraceptive Use ![[ Recorded presentation ]](/static/img/filetypes/16x16/wrf.gif){kind=small} Anshu P. Mohllajee, MPH, Kathryn M Curtis, PhD, Mary Lyn Gaffield, PhD, Herbert Peterson, MD | |||
| Breaking News: Updates on WHO's Guidelines for Contraceptive Use, Part 2 Anshu P Mohllajee, MPH, Mary Lyn Gaffield, PhD, Kathryn M Curtis, PhD, Herbert Peterson, MD | |||
| Breaking News: WHO's Guidance on Contraceptive Use for Women with HIV/AIDS Anshu P. Mohllajee, MPH, Kathryn M Curtis, PhD, Kavita Nanda, MD, MHS, Herbert Peterson, MD | |||
| TwoDay Method: A new, effective family planning option Marcos Arevalo, MD, MPH | |||
| Emergency Contraception (EC): Is it being misused? Toni L. Felice, PhD, Kay A. Armstrong, MS, Janet Adams, PhD, Paul G. Whittaker, DPhil | |||
| Characteristics of Biomedical HIV/STD/Pregnancy Prevention Methods Preferred by University Women Students Tina G. Vazin, PhD, Crystal Spivey, MPH, M. Kim Oh, MD, Tina Simpson, MD, Karyn Scissum-Gunn, PhD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | |||
| Organized by: | Population, Family Planning, and Reproductive Health | ||
| Endorsed by: | APHA-Committee on Women's Rights; International Health; Socialist Caucus; Women's Caucus | ||
| CE Credits: | CME, Health Education (CHES), Nursing | ||